+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microarray-based Diagnostics, PCR-based Diagnostics), By Application (Cancer Genetics Tests, Newborn Genetic Screening), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876217
Description Jump to:
The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion by 2030, growing at a CAGR of 4.14% from 2023 to 2030. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights

  • Based on technology, PCR-based diagnostics dominated the market in 2022 with a revenue share of 50.03% due to its extensive market usage and the wide availability of products
  • The NGS-based diagnosis segment is expected to grow at the fastest CAGR of 7.98% during the forecast period owing to the development of innovative and breakthrough advancements in the market. NGS platforms can process multiple samples in parallel, allowing for high-throughput sequencing
  • Based on application, the cancer genetics tests segment dominated the market in 2022 with a revenue share of 29.58% owing to the increase in disease outbreaks over the years
  • In terms of region, North America dominated the market in 2022 with a revenue share of 42.45%, which is attributed to several key factors, such as the presence of advanced healthcare infrastructure and robust government initiatives
  • Asia Pacific is expected to grow exponentially over the forecast period at the fastest CAGR of 6.23% owing to the growing R&D initiatives provided by governments in developing economies like China and India


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. DNA Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Technology Segment
1.1.1.2. Application Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. DNA Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Technology and Application Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. DNA Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.5. Market Restraint Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis
4.1. DNA Diagnostics Market: Technology Movement Analysis
4.2. Microarrays-based Diagnostics
4.2.1. Microarrays-based Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3. PCR-based Diagnostics
4.3.1. PCR-based Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4. In-Situ Hybridization Diagnostics
4.4.1. In-Situ Hybridization Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.5. NGS DNA Diagnosis
4.5.1. NGS DNA Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis
5.1. DNA Diagnostics Market: Application Movement Analysis
5.2. Cancer Genetics Tests
5.2.1. Cancer Genetics Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Infectious Diseases DNA Testing
5.3.1. Infectious Diseases DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. HBV Diagnostic
5.3.2.1. HBV Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. HCV Diagnostic
5.3.3.1. HCV Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. HIV Diagnostic
5.3.4.1. HIV Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. TB Diagnostic
5.3.5.1. TB Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. CT/NG Diagnostic
5.3.6.1. CT/NG Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. HPV Diagnostic
5.3.7.1. HPV Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. MRSA Diagnostic
5.3.8.1. MRSA Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Others
5.3.9.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Newborn Genetic Screening
5.4.1. Newborn Genetic Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Preimplantation & Reproductive Diagnosis
5.5.1. Preimplantation & Reproductive Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Non-Infectious Diseases DNA Testing
5.6.1. Non-Infectious Diseases DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Cardiovascular Diseases
5.6.2.1. Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. CNS & PNS Related
5.6.3.1. CNS & PNS Related Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
5.6.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Lung, Kidney, Liver & GT Related
5.6.5.1. Lung, Kidney, Liver & GT Related Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.6. Sensory Diseases
5.6.6.1. Sensory Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Prenatal DNA Carrier Screening
5.7.1. Prenatal DNA Carrier Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Pharmacogenomics/Drug Metabolism
5.8.1. Pharmacogenomics/Drug Metabolism Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Hematology & Immunology/Identity Diagnostics & Forensics
5.9.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. DNA Diagnostics Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. North America DNA Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.2.2.2. Key Country Dynamics
6.2.2.3. Regulatory Framework
6.2.2.4. Reimbursement Scenario
6.2.2.5. Competitive Scenario
6.2.3. CANADA
6.2.3.1. Canada DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.2.3.2. Key Country Dynamics
6.2.3.3. Regulatory Framework
6.2.3.4. Reimbursement Scenario
6.2.3.5. Competitive Scenario
6.3. Europe
6.3.1. Europe DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Regulatory Framework
6.3.2.4. Reimbursement Scenario
6.3.2.5. Competitive Scenario
6.3.3. GERMANY
6.3.3.1. Germany DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Regulatory Framework
6.3.3.4. Reimbursement Scenario
6.3.3.5. Competitive Scenario
6.3.4. SPAIN
6.3.4.1. Spain DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.4.2. Key Country Dynamics
6.3.4.3. Regulatory Framework
6.3.4.4. Reimbursement Scenario
6.3.4.5. Competitive Scenario
6.3.5. FRANCE
6.3.5.1. France DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.5.2. Key Country Dynamics
6.3.5.3. Regulatory Framework
6.3.5.4. Reimbursement Scenario
6.3.5.5. Competitive Scenario
6.3.6. ITALY
6.3.6.1. Italy DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.6.2. Key Country Dynamics
6.3.6.3. Regulatory Framework
6.3.6.4. Reimbursement Scenario
6.3.6.5. Competitive Scenario
6.3.7. DENMARK
6.3.7.1. Denmark DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.7.2. Key Country Dynamics
6.3.7.3. Regulatory Framework
6.3.7.4. Reimbursement Scenario
6.3.7.5. Competitive Scenario
6.3.8. SWEDEN
6.3.8.1. Sweden DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.8.2. Key Country Dynamics
6.3.8.3. Regulatory Framework
6.3.8.4. Reimbursement Scenario
6.3.8.5. Competitive Scenario
6.3.9. NORWAY
6.3.9.1. Norway DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.3.9.2. Key Country Dynamics
6.3.9.3. Regulatory Framework
6.3.9.4. Reimbursement Scenario
6.3.9.5. Competitive Scenario
6.4. Asia Pacific
6.4.1. Asia Pacific DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.2. JAPAN
6.4.2.1. Japan DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Scenario
6.4.2.5. Competitive Scenario
6.4.3. CHINA
6.4.3.1. China DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Scenario
6.4.3.5. Competitive Scenario
6.4.4. INDIA
6.4.4.1. India DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Scenario
6.4.4.5. Competitive Scenario
6.4.5. SOUTH KOREA
6.4.5.1. South Korea DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement Scenario
6.4.5.5. Competitive Scenario
6.4.6. THAILAND
6.4.6.1. Thailand DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement Scenario
6.4.6.5. Competitive Scenario
6.4.7. AUSTRALIA
6.4.7.1. Australia DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement Scenario
6.4.7.5. Competitive Scenario
6.5. Latin America
6.5.1. Latin America DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.5.2. BRAZIL
6.5.2.1. Brazil DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Competitive Scenario
6.5.3. MEXICO
6.5.3.1. Mexico DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Competitive Scenario
6.5.4. ARGENTINA
6.5.4.1. Argentina DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.5.4.2. Key Country Dynamics
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Scenario
6.5.4.5. Competitive Scenario
6.6. MEA
6.6.1. MEA DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.6.2. SOUTH AFRICA
6.6.2.1. South Africa DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. Competitive Scenario
6.6.3. SAUDI ARABIA
6.6.3.1. Saudi Arabia DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Competitive Scenario
6.6.4. UAE
6.6.4.1. UAE DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. Competitive Scenario
6.6.5. KUWAIT
6.6.5.1. Kuwait DNA Diagnostics Market, 2018 - 2030 (USD Million)
6.6.5.2. Key Country Dynamics
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Competitive Scenario
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. NEW PRODUCT LAUNCH
7.2.2. PARTNERSHIPS
7.2.3. ACQUISITION
7.2.4. COLLABORATION
7.2.5. FUNDING
7.3. Key Company Market Share Analysis, 2022
7.4. Company Heat Map Analysis
7.5. Company Profiles
7.5.1. GE HEALTHCARE
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. ABBOTT
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. BECKMAN COULTER INC.
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. BIO-RAD LABORATORIES, INC.
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. THERMO FISHER SCIENTIFIC INC.
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. ILLUMINA INC.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. CEPHEID
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. CEPHEID INC.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. HOLOGIC, INC.
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. SIEMENS HEALTHCARE GMBH
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. F. HOFFMANN-LA ROCHE
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. QIAGEN
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. AGILENT TECHNOLOGIES INC.
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 4 North America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 North America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 U.S DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 7 U.S DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 8 Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 9 Canada DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 Europe DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 11 Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 12 Europe DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 13 UK DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 UK DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 16 Germany DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 17 France DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 France DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 20 Italy DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 21 Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Spain DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 24 Denmark DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 25 Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 26 Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 28 Norway DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 30 Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 China DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 33 China DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 34 Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 Japan DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 India DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 37 India DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 38 South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 Australia DNA diagnostics market, by technology 2018 - 2030 (USD Million)
Table 41 Australia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 42 Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 45 Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 46 Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 47 Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 48 Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 49 Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 50 Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 52 Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 57 South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 61 UAE DNA diagnostics market, by application, 2018 - 2030 (USD Million)
Table 62 Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 63 Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global DNA diagnostics market - Key market driver analysis
Fig. 7 Global DNA diagnostics market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global DNA diagnostics market - Porter’s analysis
Fig. 10 Global DNA diagnostics market - PESTEL analysis
Fig. 11 Global DNA diagnostics market technology outlook key takeaways
Fig. 12 Global DNA diagnostics market: Technology movement analysis
Fig. 13 Microarrays - based based diagnostics market estimates, 2018 - 2030 (USD Million)
Fig. 14 PCR - based based diagnostics market estimates, 2018 - 2030 (USD Million)
Fig. 15 In - situ Hybridization Diagnostics market estimates, 2018 - 2030 (USD Million)
Fig. 16 NGS DNA Diagnosis market estimates, 2018 - 2030 (USD Million)
Fig. 17 Global DNA diagnostics market application outlook key takeaways
Fig. 18 Global DNA diagnostics market: application movement analysis
Fig. 19 Cancer genetics tests market estimates, 2018 - 2030 (USD Million)
Fig. 20 Infectious diseases DNA testing market estimates, 2018 - 2030 (USD Million)
Fig. 21 HBV diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 22 HCV diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 23 HIV diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 24 TB diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 25 CT/NG diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 26 HPV diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 27 MRSA diagnostic market estimates, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates, 2018 - 2030 (USD Million)
Fig. 29 Newborn genetic screening market estimates, 2018 - 2030 (USD Million)
Fig. 30 Preimplantation & reproductive diagnosis market estimates, 2018 - 2030 (USD Million)
Fig. 31 Non - infectious diseases DNA testing market estimates, 2018 - 2030 (USD Million)
Fig. 32 Cardiovascular diseases market estimates, 2018 - 2030 (USD Million)
Fig. 33 CNS & PNS related market estimates, 2018 - 2030 (USD Million)
Fig. 34 Skeletal, connective, ectodermal & dermal DNA testing market estimates, 2018 - 2030 (USD Million)
Fig. 35 Lung, kidney, liver & GT related market estimates, 2018 - 2030 (USD Million)
Fig. 36 Sensory diseases market estimates, 2018 - 2030 (USD Million)
Fig. 37 Prenatal DNA carrier screening market estimates, 2018 - 2030 (USD Million)
Fig. 38 Pharmacogenomics/drug metabolism market estimates, 2018 - 2030 (USD Million)
Fig. 39 Hematology & immunology/identity diagnostics & forensics market estimates, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates, 2018 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 Global DNA diagnostics market: Regional movement analysis
Fig. 43 North America DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 44 U.S. DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 45 Canada DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 46 Europe DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 47 UK DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 48 Germany DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 49 France DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 50 Spain DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 51 Italy DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 52 Denmark DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 53 Sweden DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 54 Norway DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 Japan DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 57 China DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 58 India DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 59 South Korea DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 60 Australia DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 61 Thailand DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 62 Latin America DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 63 Brazil DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 64 Mexico DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 65 Argentina DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 66 MEA DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 67 South Africa DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 69 UAE DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 70 Kuwait DNA diagnostics market, 2018 - 2030 (USD Million)
Fig. 71 Strategy framework

Companies Mentioned

  • GE HEALTHCARE
  • ABBOTT
  • BECKMAN COULTER INC.
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • ILLUMINA INC.
  • CEPHEID
  • CEPHEID INC.
  • HOLOGIC, INC.
  • SIEMENS HEALTHCARE GMBH
  • F. HOFFMANN-LA ROCHE
  • QIAGEN
  • AGILENT TECHNOLOGIES INC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 10.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.14 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Next Generation Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technology (LOAC & RT-PCR, Protein Microarrays), By Application, By Cancer Type, By Function, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Next Generation Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technology (LOAC & RT-PCR, Protein Microarrays), By Application, By Cancer Type, By Function, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 236 Pages
  • Global
From
Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 210 Pages
  • Global
From
DNA Probes-Based Diagnostics: Global Strategic Business Report - Product Image

DNA Probes-Based Diagnostics: Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Global Forecast to 2030 - Product Image

Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Global Forecast to 2030

  • Report
  • 209 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.